Trends in Cardiovascular Medicine
Volume 19, Issue 5 , Pages 164-169, July 2009

Galectins in Atherosclerotic Disease

  • Sali Al-Ansari
  • ,
  • Clark J. Zeebregts
  • ,
  • Riemer H.J.A. Slart
  • ,
  • Maikel Peppelenbosch

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Maikel P. Peppelenbosch, Department of Cell Biology, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands. René A. Tio, Department of Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, The Netherlands. Tel.: (+31) 503612355; fax: (+31) 503611347
  • ,
  • René A. Tio

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Maikel P. Peppelenbosch, Department of Cell Biology, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands. René A. Tio, Department of Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ Groningen, The Netherlands. Tel.: (+31) 503612355; fax: (+31) 503611347

Cardiovascular Imaging Group Groningen, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Although cells constantly adapt to external humoral cues, like cytokines and hormones, in practice, most cellular behavior is under locally guided control, via cell–cell interactions. The most prominent members of this group of molecules involved in this intercellular signaling are the galectins, a family of carbohydrate-binding proteins, which by binding specific receptors induce signaling. It has become clear that galectins are important in the pathogenesis of cardiovascular disease, in particular atherosclerosis, stroke, myocardial infarction, and heart failure. Modulation of galectin signaling holds great promise for the treatment of cardiovascular disease as evident from preclinical studies.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1050-1738(09)00154-6

doi:10.1016/j.tcm.2009.10.001

Trends in Cardiovascular Medicine
Volume 19, Issue 5 , Pages 164-169, July 2009